The Knowledge Graph Advantage — Why Plex Outperforms Standalone LLMs in Drug Discovery

LLMs sound confident but hallucinate. Plex combines a curated knowledge graph, graph algorithms, and an LLM reasoning layer to produce transparent, auditable, reproducible scientific outputs.

Plex Research Team March 9, 2026

Target Discovery in the Age of AI — How Plex Transforms a Gene Signature Into a Clinical Hypothesis

Target discovery is expensive and failure-prone. Plex offers a structured, evidence-weighted path from a raw gene expression signature to a clinically grounded target hypothesis.

Plex Research Team March 8, 2026

Biomarker Discovery — From Biological Signal to Clinical Strategy With Plex

Biomarkers define precision medicine strategy. Plex offers systematic, data-driven biomarker identification for PD markers, patient stratification, and disease diagnostics.

Plex Research Team March 7, 2026

Early Tox Signal Detection — How Plex Helps Scientists Think About Safety Before the Animal Studies

Toxicology failures remain a leading cause of drug attrition. Plex enables evidence-based safety profiling through FAERS, structural similarity, target biology, and transcriptomic tox signatures.

Plex Research Team March 6, 2026

Decoding Mechanism of Action — How Plex Connects Chemistry to Biology

MOA characterization is resource-intensive. Plex transforms it into an evidence-driven analytical process using structural similarity, transcriptomic matching, and curated MOA databases.

Plex Research Team March 5, 2026

Building on Plex — A Developer's Guide to the Plex API

Plex is a platform, not just an application. This guide covers the core API patterns — resolve, search, fetch — plus example workflows for target ID, biomarker discovery, and pipeline integration.

Plex Research Team March 4, 2026

What Every Scientific Executive Should Know About AI Deployment in 2025

The question is no longer whether to deploy AI. It's how to deploy it wisely — in ways that genuinely accelerate research and deliver measurable ROI. A framework for CSOs, VPs of Research, and Chief Scientific Decision Makers.

Brian Gilman March 3, 2026

The Buyer's Guide — Choosing a Scientific AI Platform and Understanding the Competitive Landscape

A structured buyer's framework and honest assessment of the competitive landscape — including BenevolentAI, Schrodinger, Insilico, Recursion, and others — with Plex's differentiated position.

Brian Gilman March 2, 2026

What Should Scientists Actually Look For in an AI Research Tool in 2025?

Cut through the noise. Five practical criteria for evaluating scientific AI tools — from provenance and database coverage to reproducibility and transparent methodology.

Plex Research Team March 1, 2026